Development of transcatheter intervention devices for tricuspid valve lesions_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

LV Yanmeng ,  LU Fanglin

Department of Cardiothoracic Surgery, Changhai Hospital, the Naval Medical University, Shanghai, 200433, P.R.China;

Corresponding?author：

LU Fanglin, Email: cts86227@163.com

Keywords：

Tricuspid valve regurgitation; transcatheter therapy; intervention

DOI：

10.7507/1007-4848.201705027

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Recently, several transcatheter devices for aortic valve replacement and mitral valve repair have been used in clinic, and researchers have designed a variety of tricuspid valve (TV) intervention devices. We reviewed the current status of transcatheter TV intervention, and focused on the structures of these devices and the early results of clinical trials. Undoubtedly, transcatheter intervention for TV is promising, innovational and safe for patients with severe TV regurgitation.

Citation： LV Yanmeng, LU Fanglin. Development of transcatheter intervention devices for tricuspid valve lesions. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(4): 345-349. doi: 10.7507/1007-4848.201705027 Copy

1.	王湘, 盧耀星, 李剛, 等. 對三尖瓣反流的評估及處理的意義和方法. 中國胸心血管外科臨床雜志, 2016, 23(2): 183-186.
2.	Muraru D, Surkova E, Badano LP. Revisit of functional tricuspid regurgitation; current trends in the diagnosis and management. Korean Circ J, 2016, 46(4): 443-455.
3.	Igarashi T, Tanji M, Takahashi K, et al. Predictive factor of secondary tricuspid regurgitation after aortic valve replacement for aortic stenosis: the importance of myocardial hypertrophy and diastolic dysfunction. Gen Thorac Cardiovasc Surg, 2017, 65(5): 259-266.
4.	Takano H, Hiramatsu M, Kida H, et al. Severe tricuspid regurgitation after mitral valve surgery: the risk factors and results of the aggressive application of prophylactic tricuspid valve repair. Surg Today, 2017, 47(4): 445-456.
5.	Jang JY, Heo R, Lee S, et al. Comparison of results of tricuspid valve repair versus replacement for severe functional tricuspid regurgitation. Am J Cardiol, 2017, 119(6): 905-910.
6.	Rodés-Cabau J, Taramasso M, O'Gara PT. Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet, 2016, 388(10058): 2431-2442.
7.	Jabbour RJ, Giannini F, Tanaka A, et al. Advances in percutaneous interventional therapies: the tricuspid valve. Future Cardiol, 2017, 13(3): 239-245.
8.	Auffret V, Lefevre T, Van Belle E, et al. Temporal trends in transcatheter aortic valve replacement in france: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol, 2017, 70(1): 42-55.
9.	Rogers T, Torguson R, Bastian R, et al. Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study. Am Heart J, 2017, 189: 103-109.
10.	Alozie A, Paranskaya L, Westphal B, et al. Clinical outcomes of conventional surgery versus MitraClip^? therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience. BMC Cardiovasc Disord, 2017, 17(1): 85.
11.	Luo X, Wang X, Li X, et al. Transapical transcatheter aortic valve implantation using the J-Valve system: A 1-year follow-up study. J Thorac Cardiovasc Surg, 2017, 154(1): 46-55.
12.	Liao YB, Zhao ZG, Wei X, et al. Transcatheter aortic valve implantation with the self-expandable venus A-Valve and CoreValve devices: preliminary experiences in China. Catheter Cardiovasc Interv, 2017, 89(S1): 528-533.
13.	Brüstle K, Calen C, Kuwata S, et al. How to treat tricuspid valve disease: what's new on the horizon. Curr Treat Options Cardiovasc Med, 2017, 19(3): 18.
14.	Lauten A, Ferrari M, Hekmat K, et al. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J, 2011, 32(10): 1207-1213.
15.	Rodés-Cabau J, Hahn RT, Latib A, et al. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol, 2016, 67(15): 1829-1845.
16.	Lauten A, Doenst T, Hamadanchi A, et al. Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up. Circ Cardiovasc Interv, 2014, 7(2): 268-272.
17.	Schulz E, Jabs A, Tamm A, et al. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort. Int J Cardiol, 2017, 232: 186-191.
18.	Laule M, Stangl V, Sanad W, et al. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J Am Coll Cardiol, 2013, 61(18): 1929-1931.
19.	Scarsini R, Lunardi M, Pesarini G, et al. Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves. Int J Cardiol, 2017, 235: 141-146.
20.	Lausberg HF, Gryszkiewicz R, Kuetting M, et al. Catheter-based tricuspid valve replacement: first experimental data of a newly designed bileaflet stent graft prosthesis. Eur J Cardiothorac Surg, 2017.
21.	范阜東, 何孝軍, 潘俊, 等. 左心系統瓣膜術后再次行三尖瓣手術的臨床療效分析. 中國胸心血管外科臨床雜志, 2016, 23(8): 784-787.
22.	Schueler R, Nickenig G. The Mitralign: strategies for optimal patient selection and optimised results. EuroIntervention, 2016, 12(Y): Y67-Y69.
23.	Schofer J, Bijuklic K, Tiburtius C, et al. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol, 2015, 65(12): 1190-1195.
24.	Hahn RT, Meduri CU, Davidson CJ, et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. J Am Coll Cardiol, 2017, 69(14): 1795-1806.
25.	Latib A, Agricola E, Pozzoli A, et al. First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation. JACC Cardiovasc Interv, 2015, 8(13): e211-214.
26.	Calen C, Taramasso M, Guidotti A, et al. Successful tricinch-in-tricinch transcatheter tricuspid valve repair. JACC Cardiovasc Interv, 2017, 10(8): e75-e77.
27.	Rogers T, Ratnayaka K, Sonmez M, et al. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv, 2015, 8(3): 483-491.
28.	Kuwata S, Taramasso M, Nietlispach F, et al. Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitation. Eur Heart J, 2017, 38(16): 1261.
29.	Von Bardeleben RS. Cardioband Tricuspid: A new era and gold standard through catheter. Italia: Joint Interventional Meeting 2017, 2017.
30.	Rogers JH. Transcatheter tricuspid valve therapies 5: millipede. description, results and a case. USA: Transcatheter Cardiovascular Therapeutics 2016, 2016.
31.	Campelo-Parada F, Perlman G, Philippon F, et al. First-in-man experience of a novel transcatheter repair system for treating severe tricuspid regurgitation. J Am Coll Cardiol, 2015, 66(22): 2475-2483.
32.	Rahhab Z, Kortlandt FA, Velu JF, et al. Current MitraClip experience, safety and feasibility in the Netherlands. Neth Heart J, 2017, 25(6): 394-400.
33.	Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation, 2017, 135(19): 1802-1814.
34.	McElhinney DB, Cabalka AK, Aboulhosn JA, et al. Transcatheter tricuspid valve-in-valve implantation for the treatment of dysfunctional surgical bioprosthetic valves: an international, multicenter registry study. Circulation, 2016, 133(16): 1582-1593.
35.	薛清, 徐志云, 韓林, 等. 二尖瓣成形術中輕度功能性三尖瓣反流的處理. 中國胸心血管外科臨床雜志, 2011, 18(6): 503-506.
36.	Huttin O, Voilliot D, Mandry D, et al. All you need to know about the tricuspid valve: Tricuspid valve imaging and tricuspid regurgitation analysis. Arch Cardiovasc Dis, 2016, 109(1): 67-80.

1. 王湘, 盧耀星, 李剛, 等. 對三尖瓣反流的評估及處理的意義和方法. 中國胸心血管外科臨床雜志, 2016, 23(2): 183-186.
2. Muraru D, Surkova E, Badano LP. Revisit of functional tricuspid regurgitation; current trends in the diagnosis and management. Korean Circ J, 2016, 46(4): 443-455.
3. Igarashi T, Tanji M, Takahashi K, et al. Predictive factor of secondary tricuspid regurgitation after aortic valve replacement for aortic stenosis: the importance of myocardial hypertrophy and diastolic dysfunction. Gen Thorac Cardiovasc Surg, 2017, 65(5): 259-266.
4. Takano H, Hiramatsu M, Kida H, et al. Severe tricuspid regurgitation after mitral valve surgery: the risk factors and results of the aggressive application of prophylactic tricuspid valve repair. Surg Today, 2017, 47(4): 445-456.
5. Jang JY, Heo R, Lee S, et al. Comparison of results of tricuspid valve repair versus replacement for severe functional tricuspid regurgitation. Am J Cardiol, 2017, 119(6): 905-910.
6. Rodés-Cabau J, Taramasso M, O'Gara PT. Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet, 2016, 388(10058): 2431-2442.
7. Jabbour RJ, Giannini F, Tanaka A, et al. Advances in percutaneous interventional therapies: the tricuspid valve. Future Cardiol, 2017, 13(3): 239-245.
8. Auffret V, Lefevre T, Van Belle E, et al. Temporal trends in transcatheter aortic valve replacement in france: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol, 2017, 70(1): 42-55.
9. Rogers T, Torguson R, Bastian R, et al. Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study. Am Heart J, 2017, 189: 103-109.
10. Alozie A, Paranskaya L, Westphal B, et al. Clinical outcomes of conventional surgery versus MitraClip^? therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience. BMC Cardiovasc Disord, 2017, 17(1): 85.
11. Luo X, Wang X, Li X, et al. Transapical transcatheter aortic valve implantation using the J-Valve system: A 1-year follow-up study. J Thorac Cardiovasc Surg, 2017, 154(1): 46-55.
12. Liao YB, Zhao ZG, Wei X, et al. Transcatheter aortic valve implantation with the self-expandable venus A-Valve and CoreValve devices: preliminary experiences in China. Catheter Cardiovasc Interv, 2017, 89(S1): 528-533.
13. Brüstle K, Calen C, Kuwata S, et al. How to treat tricuspid valve disease: what's new on the horizon. Curr Treat Options Cardiovasc Med, 2017, 19(3): 18.
14. Lauten A, Ferrari M, Hekmat K, et al. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J, 2011, 32(10): 1207-1213.
15. Rodés-Cabau J, Hahn RT, Latib A, et al. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol, 2016, 67(15): 1829-1845.
16. Lauten A, Doenst T, Hamadanchi A, et al. Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up. Circ Cardiovasc Interv, 2014, 7(2): 268-272.
17. Schulz E, Jabs A, Tamm A, et al. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort. Int J Cardiol, 2017, 232: 186-191.
18. Laule M, Stangl V, Sanad W, et al. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J Am Coll Cardiol, 2013, 61(18): 1929-1931.
19. Scarsini R, Lunardi M, Pesarini G, et al. Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves. Int J Cardiol, 2017, 235: 141-146.
20. Lausberg HF, Gryszkiewicz R, Kuetting M, et al. Catheter-based tricuspid valve replacement: first experimental data of a newly designed bileaflet stent graft prosthesis. Eur J Cardiothorac Surg, 2017.
21. 范阜東, 何孝軍, 潘俊, 等. 左心系統瓣膜術后再次行三尖瓣手術的臨床療效分析. 中國胸心血管外科臨床雜志, 2016, 23(8): 784-787.
22. Schueler R, Nickenig G. The Mitralign: strategies for optimal patient selection and optimised results. EuroIntervention, 2016, 12(Y): Y67-Y69.
23. Schofer J, Bijuklic K, Tiburtius C, et al. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol, 2015, 65(12): 1190-1195.
24. Hahn RT, Meduri CU, Davidson CJ, et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. J Am Coll Cardiol, 2017, 69(14): 1795-1806.
25. Latib A, Agricola E, Pozzoli A, et al. First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation. JACC Cardiovasc Interv, 2015, 8(13): e211-214.
26. Calen C, Taramasso M, Guidotti A, et al. Successful tricinch-in-tricinch transcatheter tricuspid valve repair. JACC Cardiovasc Interv, 2017, 10(8): e75-e77.
27. Rogers T, Ratnayaka K, Sonmez M, et al. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv, 2015, 8(3): 483-491.
28. Kuwata S, Taramasso M, Nietlispach F, et al. Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitation. Eur Heart J, 2017, 38(16): 1261.
29. Von Bardeleben RS. Cardioband Tricuspid: A new era and gold standard through catheter. Italia: Joint Interventional Meeting 2017, 2017.
30. Rogers JH. Transcatheter tricuspid valve therapies 5: millipede. description, results and a case. USA: Transcatheter Cardiovascular Therapeutics 2016, 2016.
31. Campelo-Parada F, Perlman G, Philippon F, et al. First-in-man experience of a novel transcatheter repair system for treating severe tricuspid regurgitation. J Am Coll Cardiol, 2015, 66(22): 2475-2483.
32. Rahhab Z, Kortlandt FA, Velu JF, et al. Current MitraClip experience, safety and feasibility in the Netherlands. Neth Heart J, 2017, 25(6): 394-400.
33. Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation, 2017, 135(19): 1802-1814.
34. McElhinney DB, Cabalka AK, Aboulhosn JA, et al. Transcatheter tricuspid valve-in-valve implantation for the treatment of dysfunctional surgical bioprosthetic valves: an international, multicenter registry study. Circulation, 2016, 133(16): 1582-1593.
35. 薛清, 徐志云, 韓林, 等. 二尖瓣成形術中輕度功能性三尖瓣反流的處理. 中國胸心血管外科臨床雜志, 2011, 18(6): 503-506.
36. Huttin O, Voilliot D, Mandry D, et al. All you need to know about the tricuspid valve: Tricuspid valve imaging and tricuspid regurgitation analysis. Arch Cardiovasc Dis, 2016, 109(1): 67-80.

Previous Article
Development and future of the minimally invasive esophagectomy for esophageal cancer
Next Article
風濕性心臟病與非風濕性心臟病患者三尖瓣置換的病例對照研究

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Development of transcatheter intervention devices for tricuspid valve lesions

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content